COCRYSTAL PHARMA, INC. Derivative Liability, Current
COCRYSTAL PHARMA, INC. (COCP) had Derivative Liability, Current of $1.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2023-03-29
- 2022-03-31: Derivative Liability, Current $1.00K.
- 2021-12-31: Derivative Liability, Current $12.00K.
- 2021-09-30: Derivative Liability, Current $34.00K.
- 2021-06-30: Derivative Liability, Current $51.00K.
| Period end | Derivative Liability, Current | Derivative Liability, Current as first filed |
|---|---|---|
| 2022-03-31 | $1.00K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $12.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $34.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $51.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $60.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $61.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $36.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $77.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $34.00K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $7.00K 10-K · filed 2021-03-17 | |
| 2019-09-30 | $90.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $123.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $163.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $263.00K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $159.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $288.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $548.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $569.00K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $855.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $707.00K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $905.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $1.48M 10-K · filed 2018-03-21 | |
| 2016-09-30 | $1.91M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $1.87M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $2.81M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $4.12M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $3.10M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $6.13M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $13.46M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $8.46M 10-Q · filed 2015-11-16 | |
| 2014-09-30 | $7.24M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $6.45M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $12.09M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $23.00K 10-Q · filed 2014-11-14 | $8.49M 10-K · filed 2014-03-31 |
| 2013-09-30 | $8.03M 10-Q · filed 2013-11-18 | |
| 2013-06-30 | $864.16K 10-Q · filed 2013-08-15 | |
| 2013-03-31 | $900.29K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $919.39K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $595.10K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $4.57M 10-Q/A · filed 2012-09-28 | |
| 2012-03-31 | $6.00M 10-Q/A · filed 2012-10-02 | |
| 2011-12-31 | $883.62K 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |